Marshall Wace
GILD icon

Marshall Wace’s Gilead Sciences GILD Stock Holding History

Marshall Wace’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3K Buy
+200
New +$26.4K ﹤0.01% 3041
2026
Q1 		– Sell
-200
Closed -$24.5K – 3390
2025
Q4 		$24.5K Buy
+200
New +$24.3K ﹤0.01% 2814
2023
Q3 		– Sell
-127,200
Closed -$9.8M – 2376
2023
Q2 		$9.8M Buy
+127,200
New +$10.1M 0.02% 735
2023
Q1 		– Sell
-68,300
Closed -$5.86M – 2826
2022
Q4 		$5.86M Buy
68,300
+5,400
+9% +$428K 0.01% 1099
2022
Q3 		$3.88M Buy
+62,900
New +$3.97M 0.01% 1568
2022
Q1 		– Sell
-205,000
Closed -$14.9M – 3576
2021
Q4 		$14.9M Sell
205,000
-93,900
-31% -$6.47M 0.03% 616
2021
Q3 		$20.9M Buy
298,900
+283,300
+1,816% +$19.9M 0.09% 257
2021
Q2 		$1.07M Sell
15,600
-24,500
-61% -$1.64M ﹤0.01% 1774
2021
Q1 		$2.59M Buy
+40,100
New +$2.59M 0.01% 1186

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace's GILD Position: Q2 2026 in Review

Marshall Wace reduced its Gilead Sciences (GILD) stake by 91% in Q2 2026, selling an estimated $277M and leaving 204,677 shares worth $25.9M. The position accounts for 0.02% of the portfolio, ranked #615.

Marshall Wace first reported a position in GILD in Q1 2014 and has held it in 42 quarters since. The position peaked at $421M in Q1 2023. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Marshall Wace held 204,677 shares of Gilead Sciences worth $25.9M as of Q2 2026.
  • Marshall Wace sold 2,105,838 Gilead Sciences shares in Q2 2026, an estimated $277M.
  • Gilead Sciences made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #615 holding.
  • Marshall Wace first reported a position in Gilead Sciences in Q1 2014 and has held it in 42 quarters since.
  • Marshall Wace's Gilead Sciences position peaked at $421M in Q1 2023.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.